| MeSH term | MeSH ID | Detail |
|---|---|---|
| Arteriosclerosis | D001161 | 86 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
Total
3
Norethindrone
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
Cross Reference
Introduction
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Norethindrone?
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Norethindrone
PubChem Associated disorders and diseases
What pathways are associated with Norethindrone
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Norethindrone?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Norethindrone?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Norethindrone?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Norethindrone?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Norethindrone?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Norethindrone
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| von Kesserü E et al. | Premenopause contraception with monthly injectable Mesigyna with special emphasis on serum lipid and bone density patterns. | 2000 | Contraception | pmid:10906502 |
| Kovacs GT et al. | A pre-coital pill? A preliminary in vitro study. | 2000 | Br J Fam Plann | pmid:10920297 |
| Dexeus S and Fernández-Cid A | [Cytological changes produced by anovulatories and intrauterine devices]. | 1975 | Acta Ginecol (Madr) | pmid:1092123 |
| Garza-Flores J and Stafford JE | Solid-phase radioimmunoassay for norethisterone. | 1979 | Clin. Chim. Acta | pmid:109237 |
| Chaudhury RR | Modern trends in contraceptive pharmacology. | 1975 | J Med Assoc Thai | pmid:1094081 |
| Grant C et al. | Management of menorrhagia in primary care-impact on referral and hysterectomy: data from the Somerset Morbidity Project. | 2000 | J Epidemiol Community Health | pmid:10942454 |
| Flodgaard D et al. | Two oral contraceptives with the same gestagen and different estrogen. A controlled clinical trial. | 1975 | Contraception | pmid:1095298 |
| Symons J et al. | Vaginal bleeding in postmenopausal women taking low-dose norethindrone acetate and ethinyl estradiol combinations. The FemHRT Study Investigators. | 2000 | Obstet Gynecol | pmid:10960627 |
| Kurman RJ et al. | Norethindrone acetate and estradiol-induced endometrial hyperplasia. | 2000 | Obstet Gynecol | pmid:10960628 |
| Kamischke A et al. | Potential of norethisterone enanthate for male contraception: pharmacokinetics and suppression of pituitary and gonadal function. | 2000 | Clin. Endocrinol. (Oxf) | pmid:10971453 |
| Dören M et al. | Resistance of pelvic arteries and plasma lipids in postmenopausal women: comparative study of tibolone and continuous combined estradiol and norethindrone acetate replacement therapy. | 2000 | Am. J. Obstet. Gynecol. | pmid:10992176 |
| Heald A et al. | Progestins abrogate estrogen-induced changes in the insulin-like growth factor axis. | 2000 | Am. J. Obstet. Gynecol. | pmid:10992179 |
| Amaro R and Barkin JS | Diagnostic and therapeutic options in obscure gastrointestinal blood loss. | 2000 | Curr Gastroenterol Rep | pmid:10998667 |
| Li C et al. | Effects of norethisterone acetate addition to estradiol in long term HRT. | 2000 | Maturitas | pmid:11006501 |
| Lethaby A et al. | Antifibrinolytics for heavy menstrual bleeding. | 2000 | Cochrane Database Syst Rev | pmid:11034679 |
| Wonodirekso S et al. | Endometrial epithelial integrity and subepithelial reticular fibre expression in progestin contraceptive acceptors. | 2000 | Hum. Reprod. | pmid:11041235 |
| Dórea JG | Oral contraceptives do not affect magnesium in breast milk. | 2000 | Int J Gynaecol Obstet | pmid:11044538 |
| Hümpel M et al. | A new principle of injectable depot contraceptives. I Drug selection and studies in monkeys. | 1979 | Contraception | pmid:110513 |
| Pierce SJ et al. | Long-term use of gonadotropin-releasing hormone analogs and hormone replacement therapy in the management of endometriosis: a randomized trial with a 6-year follow-up. | 2000 | Fertil. Steril. | pmid:11056241 |
| Albertazzi P et al. | The effect of tibolone versus continuous combined norethisterone acetate and oestradiol on memory, libido and mood of postmenopausal women: a pilot study. | 2000 | Maturitas | pmid:11063905 |
| Seeger H et al. | Effect of norethisterone acetate on estrogen metabolism in postmenopausal women. | 2000 | Horm. Metab. Res. | pmid:11069210 |
| Fábián G et al. | An unusual multiplex cause of severe gastrointestinal bleeding in a haemodialysed patient. | 2000 | Nephrol. Dial. Transplant. | pmid:11071980 |
| Irani S et al. | Pleuroperitoneal endometriosis. | 1976 | Obstet Gynecol | pmid:1107910 |
| Deckers GH et al. | Influence of the substitution of 11-methylene, delta(15), and/or 18-methyl groups in norethisterone on receptor binding, transactivation assays and biological activities in animals. | 2000 | J. Steroid Biochem. Mol. Biol. | pmid:11086227 |
| Davidson MH et al. | Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women. | 2000 | Arch. Intern. Med. | pmid:11088095 |
| Gao J et al. | Ligand-activated progesterone receptor isoform hPR-A is a stronger transactivator than hPR-B for the expression of IGFBP-1 (insulin-like growth factor binding protein-1) in human endometrial stromal cells. | 2000 | Mol. Endocrinol. | pmid:11117526 |
| Sturdee DW et al. | The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy. | 2000 | BJOG | pmid:11117768 |
| Perry W and Wiseman RA | Combined oral oestradiol valerate-norethisterone treatment over three years in postmenopausal women: correlation between oestrogen levels and bone mineral density sites. | 2000 | BJOG | pmid:11117769 |
| Eviö S et al. | Failure of the combination of sequential oral and transdermal estradiol plus norethisterone acetate to affect plasma homocysteine levels. | 2000 | Fertil. Steril. | pmid:11119731 |
| Björn I et al. | Negative mood changes during hormone replacement therapy: a comparison between two progestogens. | 2000 | Am. J. Obstet. Gynecol. | pmid:11120505 |
| Briggs MH and Briggs M | Thiamine status and oral contraceptives. | 1975 | Contraception | pmid:1112084 |
| Speroff L et al. | The effect of varying low-dose combinations of norethindrone acetate and ethinyl estradiol (femhrt) on the frequency and intensity of vasomotor symptoms. | 2000 Nov-Dec | Menopause | pmid:11127760 |
| Shojania AM et al. | The effect of oral contraceptives on folate metabolism. III. Plasma clearance and urinary folate excretion. | 1975 | J. Lab. Clin. Med. | pmid:1113011 |
| Cornu C et al. | Postmenopause hormone treatment in women with NIDDM or impaired glucose tolerance: the MEDIA randomized clinical trial. | 2000 | Maturitas | pmid:11137328 |
| Chihal HJ et al. | Estrogen potency of oral contraceptive pills. | 1975 | Am. J. Obstet. Gynecol. | pmid:1115120 |
| Plumb JM and Guest JF | Economic impact of tibolone compared with continuous-combined hormone replacement therapy. In the management of postmenopausal women with climacteric symptoms in the UK. | 2000 | Pharmacoeconomics | pmid:11151401 |
| Doyle LL | Hormone-releasing silicone-rubber intrauterine contraceptive devices. Effect of incorporation of various compounds on intrauterine contraceptive devices in rats. | 1975 | Am. J. Obstet. Gynecol. | pmid:1115155 |
| Alexandersen P et al. | Efficacy of levormeloxifene in the prevention of postmenopausal bone loss and on the lipid profile compared to low dose hormone replacement therapy. | 2001 | J. Clin. Endocrinol. Metab. | pmid:11158042 |
| Gravholt CH et al. | Reduced free IGF-I and increased IGFBP-3 proteolysis in Turner syndrome: modulation by female sex steroids. | 2001 | Am. J. Physiol. Endocrinol. Metab. | pmid:11158935 |
| Schoonen WG et al. | Hormonal properties of norethisterone, 7alpha-methyl-norethisterone and their derivatives. | 2000 | J. Steroid Biochem. Mol. Biol. | pmid:11162927 |
| Bai J et al. | Regulation of invasive cell behavior by taiman, a Drosophila protein related to AIB1, a steroid receptor coactivator amplified in breast cancer. | 2000 | Cell | pmid:11163181 |
| McGuire JL et al. | Effects of low dose oral contraceptives containing norethindrome and ethinyl estradiol on serum levels of progesterone and pituitary gonadotropins. | 1975 | Contraception | pmid:1116369 |
| Teede HJ et al. | Effects of oral combined hormone replacement therapy on platelet aggregation in postmenopausal women. | 2001 | Clin. Sci. | pmid:11171290 |
| Cardim HJ et al. | The insulin-like growth factor-I system and hormone replacement therapy. | 2001 | Fertil. Steril. | pmid:11172828 |
| Sørensen MB et al. | Temporal changes in cardiac function and cerebral blood flow during sequential postmenopausal hormone replacement. | 2001 | Am. J. Obstet. Gynecol. | pmid:11174477 |
| Prasad AS et al. | Effect of oral contraceptive agents on nutrients: I. Minerals. | 1975 | Am. J. Clin. Nutr. | pmid:1119434 |
| Margen S and King JC | Effect of oral contraceptive agents on the metabolism of some trace minerals. | 1975 | Am. J. Clin. Nutr. | pmid:1119435 |
| Walker RJ et al. | The effects of sequential combined oral 17beta-estradiol norethisterone acetate on insulin sensitivity and body composition in healthy postmenopausal women: a randomized single blind placebo-controlled study. | 2001 Jan-Feb | Menopause | pmid:11201511 |
| Seeger H et al. | Effect of medroxyprogesterone acetate and norethisterone on serum-stimulated and estradiol-inhibited proliferation of human coronary artery smooth muscle cells. | 2001 Jan-Feb | Menopause | pmid:11201515 |
| Ursic-Vrscaj M et al. | Hormone replacement therapy after invasive ovarian serous cystadenocarcinoma treatment: the effect on survival. | 2001 Jan-Feb | Menopause | pmid:11201519 |